Polomar Health Services, Inc.
corporate_fare Company Profile
Polomar Health Services, Inc. (OTC:PMHS) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 18 items for PMHS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 8/10. Across its 18 most recent items scored 7 or higher, the top rating is 10/10, with 15 rated 8 or above. Recent SEC coverage for PMHS spans 10-Q, 8-K, 10-K, DEFM14C.
Recent high-impact activity:
- Polomar 10-Q: Q3 Revenue $1.13M, Restatement Adds $490K to Losses, Going Concern Doubt
- Polomar Converts $450,000 in Owed Commissions Into 10% Note Due March 2027
- Polomar Pulls Two Quarterly Reports, Expects ~$421K Additional Net Loss and Material Weaknesses
- Polomar Loses Two Directors in One Day, Board Cut From Five to Three
- Polomar Health Q2 Revenue Jumps to $1.5M, Turns Profitable, But Going Concern and Material Weaknesses Persist
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 1,712 shares in PMHS as of the October 30, 2026 settlement, a 100.0% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 19, 2026, 100.0% of PMHS volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.